Capital Grand Est
Francecapitalgrandest.eu
Overview
Capital Grand Est is an independent private equity firm that supports companies in the Grand Est region of France (Alsace, Champagne-Ardenne, and Lorraine). It provides equity and quasi-equity financing to support companies' development and buyout projects, from creation through growth. The firm was created in 2017 from the merger of the Institut Lorrain de Participation and Capital Investissement en Alsace (CIIA).
Portfolio Companies
15
Website
capitalgrandest.euInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Apmonia Therapeutics | Feb 2026 | Series A | Co-investor |
| Dianosic | Nov 2025 | Series A | Co-investor |
| EVerZom | Oct 2025 | Series A | Lead |
| Elkedonia | Jun 2025 | Seed | Co-investor |
| Fizimed | Mar 2025 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
